John Cumming
Director/Board Member chez T2 BIOSYSTEMS, INC.
Fortune : 156 $ au 31/03/2024
Profil
John W.
Cumming founded HealthCare Markets Group in 1984, where he worked as President & Managing Director.
Mr. Cumming also currently works at Cumming & Associates LLC, as Chief Executive Officer & Managing Director from 2014, T2 Biosystems, Inc., as Lead Independent Director from 2020, Transmed7 LLC, as Director, and Bentley University, as Trustee.
Mr. Cumming also formerly worked at Hologic, Inc., as Chief Executive Officer in 2013, Lorad Corp, as President in 2001, and Elscint, Inc., as Vice President & Division Manager.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
T2 BIOSYSTEMS, INC.
0,00% | 01/03/2024 | 52 ( 0,00% ) | 156 $ | 31/03/2024 |
Postes actifs de John Cumming
| Sociétés | Poste | Début |
|---|---|---|
| T2 BIOSYSTEMS, INC. | Director/Board Member | 01/07/2014 |
| Bentley University | Director/Board Member | 24/01/2011 |
Cumming & Associates LLC
 Cumming & Associates LLC Miscellaneous Commercial ServicesCommercial Services Cumming & Associates LLC is a private company that provides services related to nutrition and sports. The company is based in Dover, DE. The company offers solutions to activate the environment and provide large-scale malevolent ornare. John W. Cumming has been the CEO of the company since 2014. | Chief Executive Officer | 01/07/2014 |
Transmed7 LLC
 Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Director/Board Member | - |
Anciens postes connus de John Cumming
| Sociétés | Poste | Fin |
|---|---|---|
| HOLOGIC, INC. | Chief Executive Officer | 07/12/2013 |
Lorad Corp
 Lorad Corp Medical SpecialtiesHealth Technology Lorad Corp manufactured diagnostics products, medical imaging systems and surgical products for women. It provided aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays. The company was founded on June 11, 1984 and was headquartered in Danbury, CT. | President | 01/07/2001 |
| Elscint, Inc. | Corporate Officer/Principal | - |
| HealthCare Markets Group | Founder | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HOLOGIC, INC. | Health Technology |
| T2 BIOSYSTEMS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Lorad Corp
Lorad Corp Medical SpecialtiesHealth Technology Lorad Corp manufactured diagnostics products, medical imaging systems and surgical products for women. It provided aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays. The company was founded on June 11, 1984 and was headquartered in Danbury, CT. | Health Technology |
| HealthCare Markets Group | |
| Elscint, Inc. | |
Cumming & Associates LLC
Cumming & Associates LLC Miscellaneous Commercial ServicesCommercial Services Cumming & Associates LLC is a private company that provides services related to nutrition and sports. The company is based in Dover, DE. The company offers solutions to activate the environment and provide large-scale malevolent ornare. John W. Cumming has been the CEO of the company since 2014. | Commercial Services |
Transmed7 LLC
Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Health Technology |
